New Delhi, July 28 -- After hitting 10 per cent lower circuit on Tuesday, Dr Reddy's shares have further extended its downside trend and crashed more than 3 per cent in the intraday trade session. According to stock market experts, this heavy beating in the pharma stock is mainly due to the lower than expected Dr Reddy's Q1 results. They said that markets was expecting rise in its profit while it reported slump in its quarterly profit. However, they maintained that such dip in Dr Reddy's share price should be seen as an opportunity to take 'positional call' in the counter as triggers like Sputnik vaccine manufacturing in India from September this year and fear of third wave are still around.

Speaking on the triggers that is expected to f...